Literature DB >> 17213357

Massive expansion of EBV+ monoclonal T cells with CD5 down regulation in EBV-associated haemophagocytic lymphohistiocytosis.

Ming-Tsan Lin1, Hui-Mei Chang, Chang-Jen Huang, Woan-Ling Chen, Chi-Yung Lin, Ching-Yang Lin, Shih-Sung Chuang.   

Abstract

Haemophagocytic lymphohistiocytosis (HLH) comprises primary and secondary forms; the secondary form is most commonly triggered by the Epstein-Barr virus (EBV; EBV-HLH). Patients with EBV-HLH usually exhibit oligoclonal or monoclonal T cell proliferation, which may mimic T cell lymphoproliferative disorder (T-LPD). This article reports on EBV-HLH in a 17-month-old girl with an extreme surge of reactive T lymphocytosis (absolute count 167x10(9)/l) with CD5 down regulation. Bone marrow aspirate and trephine contained florid haemophagocytosis and massive infiltration of CD3+ Epstein-Barr virus-encoded RNA+ lymphocytes, as seen by double labelling. These lymphocytes were monoclonal for EBV and T cell receptor gamma chain gene rearrangement. The patient responded dramatically to intravenous immunoglobulin, interferon alpha2b, ganciclovir and prednisolone, suggesting restoration of her immune system and eradication of the clonal T cells through these immunoregulatory agents. Thus, careful clinicopathological correlation is warranted in the interpretation of immunophenotyping and clonality data in T cell proliferation in association with EBV-HLH to avoid erroneous diagnosis of T-LPD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17213357      PMCID: PMC1860609          DOI: 10.1136/jcp.2005.034371

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  Quantitative analysis of cell-free Epstein-Barr virus genome copy number in patients with EBV-associated hemophagocytic lymphohistiocytosis.

Authors:  Tomoko Teramura; Yasuhiro Tabata; Tomohito Yagi; Akira Morimoto; Shigeyoshi Hibi; Shinsaku Imashuku
Journal:  Leuk Lymphoma       Date:  2002-01

2.  Immunophenotypic analysis of peripheral T-cell neoplasms. A multiparameter flow cytometric approach.

Authors:  S Jamal; L J Picker; D B Aquino; R W McKenna; D B Dawson; S H Kroft
Journal:  Am J Clin Pathol       Date:  2001-10       Impact factor: 2.493

Review 3.  Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

Authors:  Shinsaku Imashuku
Journal:  Crit Rev Oncol Hematol       Date:  2002-12       Impact factor: 6.312

4.  Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions.

Authors:  Eiichi Ishii; Ikuyo Ueda; Ryutaro Shirakawa; Ken Yamamoto; Hisanori Horiuchi; Shouichi Ohga; Kenji Furuno; Akira Morimoto; Miyoko Imayoshi; Yoshiyasu Ogata; Masafumi Zaitsu; Masahiro Sako; Kenichi Koike; Akifumi Sakata; Hidetoshi Takada; Toshiro Hara; Shinsaku Imashuku; Takehiko Sasazuki; Masaki Yasukawa
Journal:  Blood       Date:  2005-01-04       Impact factor: 22.113

5.  Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society.

Authors:  J I Henter; G Elinder; A Ost
Journal:  Semin Oncol       Date:  1991-02       Impact factor: 4.929

6.  Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome.

Authors:  H Kawaguchi; T Miyashita; H Herbst; G Niedobitek; M Asada; M Tsuchida; R Hanada; A Kinoshita; M Sakurai; N Kobayashi
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

7.  Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome.

Authors:  L Quintanilla-Martinez; S Kumar; F Fend; E Reyes; J Teruya-Feldstein; D W Kingma; L Sorbara; M Raffeld; S E Straus; E S Jaffe
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

8.  A simplified method of detection of clonal rearrangements of the T-cell receptor-gamma chain gene.

Authors:  K P McCarthy; J P Sloane; J H Kabarowski; E Matutes; L M Wiedemann
Journal:  Diagn Mol Pathol       Date:  1992-09

9.  An approach to diagnosis of T-cell lymphoproliferative disorders by flow cytometry.

Authors:  Wojciech Gorczyca; James Weisberger; Z Liu; Patricia Tsang; Monowar Hossein; C Daniel Wu; Henry Dong; John Y L Wong; Sorina Tugulea; Simpson Dee; Myron R Melamed; Zbigniew Darzynkiewicz
Journal:  Cytometry       Date:  2002-06-15

10.  Comparative evaluation of PCR-based methods for the assessment of T cell clonality in the diagnosis of T cell lymphoma.

Authors:  Suzanne M Cairns; Jeremy M E Taylor; Paul R Gould; Dominic V Spagnolo
Journal:  Pathology       Date:  2002-08       Impact factor: 5.306

View more
  10 in total

1.  Immunophenotypic profile in acute infectious mononucleosis mimicking malignant lymphoproliferative disorder: a case report and review of literature.

Authors:  Prashant Tembhare; Manisha Ramani; Keerti Syed; Amar Das Gupta
Journal:  Indian J Hematol Blood Transfus       Date:  2010-09-30       Impact factor: 0.900

2.  Combining an antiviral with rituximab in EBV-related haemophagocytic lymphohistiocytosis led to rapid viral clearance; and a comprehensive review.

Authors:  Christos Stefanou; Christiana Tzortzi; Fotini Georgiou; Chrystalla Timiliotou
Journal:  BMJ Case Rep       Date:  2016-12-09

Review 3.  The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.

Authors:  Megan C Smith; Daniel N Cohen; Bruce Greig; Ashwini Yenamandra; Cindy Vnencak-Jones; Mary Ann Thompson; Annette S Kim
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

4.  Flow cytometric findings in hemophagocytic lymphohistiocytosis.

Authors:  Chad M McCall; Shiyama Mudali; Robert J Arceci; Donald Small; Shirley Fuller; Christopher D Gocke; Milena Vuica-Ross; Kathleen H Burns; Michael J Borowitz; Amy S Duffield
Journal:  Am J Clin Pathol       Date:  2012-05       Impact factor: 2.493

5.  T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis.

Authors:  Vandana Chaturvedi; Rebecca A Marsh; Adi Zoref-Lorenz; Erika Owsley; Vijaya Chaturvedi; Trung C Nguyen; Jordana R Goldman; Michael M Henry; Jay N Greenberg; Stephan Ladisch; Michelle L Hermiston; Michael Jeng; Ahmed Naqvi; Carl E Allen; Hector R Wong; Michael B Jordan
Journal:  Blood       Date:  2021-04-29       Impact factor: 25.476

6.  Greater frequency of CD5-negative CD8(+) T cells against human immunodeficiency virus type 1 than other viruses is consistent with adaptation to antigenic variation.

Authors:  Stephen J Penney; Maureen E Gallant; Michael D Grant
Journal:  AIDS Res Ther       Date:  2014-09-15       Impact factor: 2.250

7.  First report on familial hemophagocytic lymphohistiocytosis with an abnormal immunophenotype and T cell monoclonality in Korea.

Authors:  Sang-Yong Shin; Kyunghoon Lee; Mi-Ae Jang; Seung-Tae Lee; Keon Hee Yoo; Hong Hoe Koo; Dae Shick Kim; Hee-Jin Kim; Sun-Hee Kim
Journal:  Ann Lab Med       Date:  2014-12-08       Impact factor: 3.464

8.  EBV-Positive T/NK-Cell Lymphoproliferative Disease of Childhood.

Authors:  Mineui Hong; Young Hyeh Ko; Keon Hee Yoo; Hong Hoe Koo; Seok Jin Kim; Won Seog Kim; Heejung Park
Journal:  Korean J Pathol       Date:  2013-04-24

Review 9.  Understanding organ dysfunction in hemophagocytic lymphohistiocytosis.

Authors:  Caroline Créput; Lionel Galicier; Sophie Buyse; Elie Azoulay
Journal:  Intensive Care Med       Date:  2008-04-22       Impact factor: 41.787

10.  T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH.

Authors:  Oded Shamriz; Deepak Kumar; Jenny Shim; Michael Briones; Maa-Ohui Quarmyne; Satheesh Chonat; Laura Lucas; Holly Edington; Michael H White; Advay Mahajan; Sunita Park; Shanmuganathan Chandrakasan
Journal:  J Clin Immunol       Date:  2021-06-26       Impact factor: 8.317

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.